查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829782

2025年全球肺部给药设备市场报告

Pulmonary Drug Delivery Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，肺部给药设备市场规模强劲成长，从2024年的495.2亿美元增加至2025年的528亿美元，复合年增长率为6.6%。这段时期的成长可归因于慢性阻塞性肺病(COPD)、气喘和囊肿纤维化等呼吸系统疾病的盛行率不断上升、全球人口老化、人们对呼吸卫生重要性的认识不断提高、新兴国家医疗保健支出不断增加以及居家照护呼吸治疗的普及率不断提高。

预计未来几年肺部给药装置市场将强劲成长，到 2029 年将达到 681.8 亿美元，年复合成长率（CAGR）为 6.6%。预测期内的增长可归因于呼吸护理中对个人化和精准医疗的需求不断增长、家庭医疗保健服务和远端患者监护的扩展、研发投资的增加以及对预防保健和早期疗育策略的更多关注。预测期内的主要趋势包括技术创新、向基于价值的护理模式和以患者为中心的方法的转变、将远端医疗和远端监控功能整合到呼吸治疗平台、使用穿戴式装置和行动应用程式进行呼吸疾病自我管理，以及采用 3D 列印和数位製造技术。

肺部给药装置是一种用于将药物直接输送至肺部的吸入装置。这些装置能够实现标靶给药，以治疗气喘和慢性阻塞性肺病(COPD) 等呼吸系统疾病。肺部给药也能促进胰岛素和止痛药等药物的全身性吸收。

肺部给药装置的主要类型包括干粉吸入器、定量吸入器和雾化器。干粉吸入器将定量的药物以细干粉的形式分配，患者可直接吸入肺部。这类装置用于治疗气喘、囊肿纤维化和慢性阻塞性肺病等疾病。它们透过零售药局、医院药局和电商等管道销售。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供肺部给药装置市场统计数据，例如全球市场规模、区域份额、肺部给药装置市场份额的竞争对手、详细的肺部给药装置细分市场、市场趋势以及肺部给药装置行业的商机。这些肺部给药装置市场研究报告对该行业的现状和未来情况进行了详细分析，为您提供所需的一切资讯的完整展望。

未来五年6.6%的预测成长率，较我们先前对该市场的预测略有下降0.5%。这一下降主要源自于美国与其他国家之间关税的影响。这种影响可能会直接影响美国，具体表现为对主要从英国和韩国进口的振动筛孔式喷雾器板和剂量计数装置的关税上调，从而提高呼吸系统药物输送的成本。此外，由于互惠关税以及贸易紧张局势和限制措施加剧对全球经济和贸易的负面影响，这种影响也将更加广泛地显现。

预计呼吸系统疾病的日益普及将推动未来肺部给药装置市场的成长。呼吸系统疾病是一种影响肺部和呼吸道并损害人类呼吸的疾病或状况。呼吸系统疾病盛行率的上升归因于多种因素，包括空气污染水平上升、吸烟率上升、都市化、气候变迁和人口老化。肺部给药装置透过将药物直接输送到肺部，在治疗呼吸系统疾病中发挥关键作用。例如，2024 年 5 月，美国国家公共卫生机构疾病管制与预防中心 (CDC) 报告称，目前 18 岁及以上成年人气喘的盛行率从 2021 年的 8.0% 上升到 2022 年的 8.7%。因此，预计呼吸系统疾病盛行率的上升将推动肺部给药装置市场的成长。

肺部给药设备市场的主要企业正在开发创新产品，例如小容量雾化器，以便透过先进功能更好地服务客户。小容量雾化器 (SVN) 是医疗设备，用于将液体药物以气溶胶雾的形式输送给患有气喘、慢性阻塞性肺病) 和囊肿纤维化等呼吸系统疾病的患者。例如，2024 年 5 月，美国医疗保健公司 Medline Industries, LP 推出了Hudson RCI Turbo Mist 小容量雾化器。这种突破性设备旨在短短三分钟内输送药物。与标准雾化器相比，这款创新雾化器每分钟可输送 2.5 倍以上的药物，将治疗时间缩短约 70%。治疗时间的减少使医疗保健提供者受益，因为它可以透过缩短治疗时间来优化患者吞吐量并改善患者体验。

2022年8月，瑞士製药公司山德士集团（Sandoz Group AG）收购了Coalesce Product Development Limited，收购金额未揭露。山德士旨在透过此次收购增强其抽吸治疗产品组合，并改善患者获得高品质、复杂治疗方法。 Coalesce Product Development Limited总部位于英国，提供肺部给药装置。

肺部给药设备市场的主要参与者包括美敦力公司、液化空气公司、碧迪公司、荷兰皇家飞利浦公司、Medline Industries Inc.、ResMed Inc.、Dragerwerk AG And Co.KGaA、Smiths Group plc、AptarGroup Inc.、Chiesi Farmaceutici. Inc.、Drive DeVilbiss Healthcare Inc.、Hovione、Hamilton Medical AG、GaleMed Corporation、Allied Healthcare Products Inc.、Precision Medical Inc.、Salter Labs Inc. 和 Nidek Medical Products Inc.。

2024 年，北美是肺部给药装置市场最大的地区。肺部给药装置市场报告涵盖的地区包括亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。

肺部给药装置市场报告涉及的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、加拿大、义大利和西班牙。

肺部给药设备市场包括喷射雾化器、超音波雾化器和振动网状雾化器的销售。该市场的数据为“出厂价”，即产品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户的销售。该市场的商品价值还包括产品製造商提供的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球肺部给药装置：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球肺部给药装置市场：成长率分析
  • 全球肺部给药设备市场表现：规模与成长，2019-2024
  • 全球肺部给药设备市场预测：规模与成长，2024-2029年，2034年
  • 全球肺部给药装置：总目标市场（TAM）

第六章 市场细分

  • 全球肺部给药设备市场：依产品类型、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 干粉吸入器
  • 定量喷雾吸入器
  • 喷雾器
  • 全球肺部给药设备市场：应用、绩效及预测（2019-2024年、2024-2029年、2034年）
  • 气喘
  • 囊肿纤维化
  • 慢性阻塞性肺病
  • 其他用途
  • 全球肺部给药设备市场：依分销管道、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 零售药局
  • 医院药房
  • 电子商务
  • 全球肺部给药设备市场：按干粉吸入器（DPI）细分，类型，实际和预测，2019-2024 年，2024-2029 年，2034 年
  • 单剂量DPI
  • 多剂量DPI
  • 全球肺部给药设备市场：定量喷雾吸入器(MDI) 细分，类型，实际及预测，2019-2024 年，2024-2029 年，2034 年
  • 含氯氟烃的MDI
  • 基于HFA的MDI
  • 全球肺部给药设备市场：依雾化器类型细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 喷射雾化器
  • 超音波雾化器
  • 网状雾化器

第七章 区域和国家分析

  • 全球肺部给药装置市场：区域分析、预测与成长，2019-2024 年、2024-2029 年、2034 年
  • 全球肺部给药设备市场：国家、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 肺部给药设备市场：竞争格局
  • 肺部给药装置市场：公司简介
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Air Liquide SA Overview, Products and Services, Strategy and Financial Analysis
    • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • Koninklijke Philips NV Overview, Products and Services, Strategy and Financial Analysis
    • Medline Industries Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • ResMed Inc.
  • Dragerwerk AG And Co. KGaA
  • Smiths Group plc
  • AptarGroup Inc.
  • Chiesi Farmaceutici SpA
  • Teleflex Incorporated
  • Masimo Corporation
  • Fisher And Paykel Healthcare Limited
  • Invacare Corporation
  • Vyaire Medical Inc.
  • Inogen Inc.
  • Drive DeVilbiss Healthcare Inc.
  • Hovione
  • Hamilton Medical AG
  • GaleMed Corporation

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年肺部给药设备市场：提供新机会的国家
  • 2029年肺部给药设备市场：细分市场将带来新机会
  • 2029年肺部给药设备市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r31038u

Pulmonary drug delivery devices are inhalation devices designed to administer medications directly to the lungs. These devices enable targeted drug delivery for treating respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). Additionally, pulmonary delivery allows for the systemic absorption of drugs such as insulin and pain medications.

The primary types of pulmonary drug delivery devices include dry powder inhalers, metered dose inhalers, and nebulizers. Dry powder inhalers dispense a measured dose of medication in a fine, dry powder form that the patient inhales directly into their lungs. These devices are used for conditions such as asthma, cystic fibrosis, chronic obstructive pulmonary disease, and others. They are distributed through channels such as retail pharmacies, hospital pharmacies, and e-commerce.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The pulmonary drug delivery devices market research report is one of a series of new reports from The Business Research Company that provides pulmonary drug delivery devices market statistics, including the pulmonary drug delivery devices industry global market size, regional shares, competitors with pulmonary drug delivery devices market share, detailed pulmonary drug delivery devices market segments, market trends, and opportunities, and any further data you may need to thrive in the pulmonary drug delivery devices industry. These pulmonary drug delivery devices market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pulmonary drug delivery devices market size has grown strongly in recent years. It will grow from $49.52 billion in 2024 to $52.8 billion in 2025 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to the increasing prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis, the growing aging population worldwide, rising awareness about the importance of respiratory health, expansion of healthcare expenditure in emerging economies, and increasing adoption of homecare settings for respiratory therapy.

The pulmonary drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $68.18 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to the growing demand for personalized and precision medicine in respiratory care, expansion of home healthcare services and remote patient monitoring, rising investments in research and development, and increasing focus on preventive healthcare and early intervention strategies. Major trends in the forecast period include technological innovations, the shift towards value-based care models and patient-centric approaches, the integration of telehealth and remote monitoring capabilities into respiratory therapy platforms, the utilization of wearables and mobile applications for self-management of respiratory conditions, and the adoption of 3D printing and digital manufacturing techniques.

The forecast of 6.6% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through increased tariffs on vibrating mesh nebulizer plates and dose-counting mechanisms, mainly imported from the UK and South Korea, raising costs for respiratory medication administration.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing prevalence of respiratory disorders is expected to drive the growth of the pulmonary drug delivery devices market in the future. Respiratory disorders are diseases or conditions that affect the lungs and airways, impairing human respiration. The increasing prevalence of respiratory disorders is due to several factors, such as rising levels of air pollution, increased smoking rates, urbanization, climate change, and an aging population. Pulmonary drug delivery devices play a crucial role in treating respiratory disorders by enabling direct medication delivery to the lungs. For example, in May 2024, the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, reported that the prevalence of current asthma among adults aged 18 and over increased from 8.0% in 2021 to 8.7% in 2022. Thus, the rising prevalence of respiratory disorders is expected to drive the growth of the pulmonary drug delivery devices market.

Major companies in the pulmonary drug delivery devices market are developing innovative products, such as small-volume nebulizers, to better serve customers with advanced features. A small-volume nebulizer (SVN) is a medical device used to deliver liquid medication in the form of an aerosolized mist to patients with respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), or cystic fibrosis. For instance, in May 2024, Medline Industries, LP, a US-based healthcare company, launched the Hudson RCI TurboMist small-volume nebulizer. This groundbreaking device is designed to deliver medication treatments quickly, in as little as three minutes. The innovative nebulizer can dispense 2.5 times more medication per minute compared to standard nebulizers, reducing treatment times by about 70%. This increase in medication delivery significantly reduces treatment times, benefiting healthcare providers by optimizing patient throughput and enhancing the patient experience by shortening the duration of therapy sessions.

In August 2022, Sandoz Group AG, a Switzerland-based pharmaceutical company, acquired Coalesce Product Development Limited for an undisclosed amount. Through this acquisition, Sandoz aims to strengthen its portfolio of respiratory medicines and improve patient access to high-quality, complex therapies. Coalesce Product Development Limited is a UK-based company that provides pulmonary drug delivery devices.

Major companies operating in the pulmonary drug delivery devices market are Medtronic plc, Air Liquide S.A., Becton Dickinson and Company, Koninklijke Philips N.V., Medline Industries Inc., ResMed Inc., Dragerwerk AG And Co. KGaA, Smiths Group plc, AptarGroup Inc., Chiesi Farmaceutici S.p.A., Teleflex Incorporated, Masimo Corporation, Fisher And Paykel Healthcare Limited, Invacare Corporation, Vyaire Medical Inc., Inogen Inc., Drive DeVilbiss Healthcare Inc., Hovione, Hamilton Medical AG, GaleMed Corporation, Allied Healthcare Products Inc., Precision Medical Inc., Salter Labs Inc., Nidek Medical Products Inc.

North America was the largest region in the pulmonary drug delivery devices market in 2024. The regions covered in the pulmonary drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pulmonary drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The pulmonary drug delivery devices market consists of sales of jet nebulizers, ultrasonic wave nebulizers, and vibrating mesh nebulizers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pulmonary Drug Delivery Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pulmonary drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pulmonary drug delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pulmonary drug delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Dry Powder Inhalers; Metered Dose Inhalers; Nebulizers
  • 2) By Application: Asthma; Cystic Fibrosis; Chronic Obstructive Pulmonary Disease; Other Applications
  • 3) By Distribution Channel: Retail Pharmacies; Hospital Pharmacies; E-Commerce
  • Subsegments:
  • 1) By Dry Powder Inhalers (DPIs): Single-Dose DPIs; Multi-Dose DPIs
  • 2) By Metered Dose Inhalers (MDIs): CFC-Based MDIs; HFA-Based MDIs
  • 3) By Nebulizers: Jet Nebulizers; Ultrasonic Nebulizers; Mesh Nebulizers
  • Companies Mentioned: Medtronic plc; Air Liquide S.A.; Becton Dickinson and Company; Koninklijke Philips N.V.; Medline Industries Inc.; ResMed Inc.; Dragerwerk AG And Co. KGaA; Smiths Group plc; AptarGroup Inc.; Chiesi Farmaceutici S.p.A.; Teleflex Incorporated; Masimo Corporation; Fisher And Paykel Healthcare Limited; Invacare Corporation; Vyaire Medical Inc.; Inogen Inc.; Drive DeVilbiss Healthcare Inc.; Hovione; Hamilton Medical AG; GaleMed Corporation; Allied Healthcare Products Inc.; Precision Medical Inc.; Salter Labs Inc.; Nidek Medical Products Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pulmonary Drug Delivery Devices Market Characteristics

3. Pulmonary Drug Delivery Devices Market Trends And Strategies

4. Pulmonary Drug Delivery Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Pulmonary Drug Delivery Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Pulmonary Drug Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Pulmonary Drug Delivery Devices Market Growth Rate Analysis
  • 5.4. Global Pulmonary Drug Delivery Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Pulmonary Drug Delivery Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Pulmonary Drug Delivery Devices Total Addressable Market (TAM)

6. Pulmonary Drug Delivery Devices Market Segmentation

  • 6.1. Global Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Dry Powder Inhalers
  • Metered Dose Inhalers
  • Nebulizers
  • 6.2. Global Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Asthma
  • Cystic Fibrosis
  • Chronic Obstructive Pulmonary Disease
  • Other Applications
  • 6.3. Global Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Retail Pharmacies
  • Hospital Pharmacies
  • E-Commerce
  • 6.4. Global Pulmonary Drug Delivery Devices Market, Sub-Segmentation Of Dry Powder Inhalers (DPIs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Dose DPIs
  • Multi-Dose DPIs
  • 6.5. Global Pulmonary Drug Delivery Devices Market, Sub-Segmentation Of Metered Dose Inhalers (MDIs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • CFC-Based MDIs
  • HFA-Based MDIs
  • 6.6. Global Pulmonary Drug Delivery Devices Market, Sub-Segmentation Of Nebulizers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Jet Nebulizers
  • Ultrasonic Nebulizers
  • Mesh Nebulizers

7. Pulmonary Drug Delivery Devices Market Regional And Country Analysis

  • 7.1. Global Pulmonary Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Pulmonary Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pulmonary Drug Delivery Devices Market

  • 8.1. Asia-Pacific Pulmonary Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pulmonary Drug Delivery Devices Market

  • 9.1. China Pulmonary Drug Delivery Devices Market Overview
  • 9.2. China Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pulmonary Drug Delivery Devices Market

  • 10.1. India Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pulmonary Drug Delivery Devices Market

  • 11.1. Japan Pulmonary Drug Delivery Devices Market Overview
  • 11.2. Japan Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pulmonary Drug Delivery Devices Market

  • 12.1. Australia Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pulmonary Drug Delivery Devices Market

  • 13.1. Indonesia Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pulmonary Drug Delivery Devices Market

  • 14.1. South Korea Pulmonary Drug Delivery Devices Market Overview
  • 14.2. South Korea Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pulmonary Drug Delivery Devices Market

  • 15.1. Western Europe Pulmonary Drug Delivery Devices Market Overview
  • 15.2. Western Europe Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pulmonary Drug Delivery Devices Market

  • 16.1. UK Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pulmonary Drug Delivery Devices Market

  • 17.1. Germany Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pulmonary Drug Delivery Devices Market

  • 18.1. France Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pulmonary Drug Delivery Devices Market

  • 19.1. Italy Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pulmonary Drug Delivery Devices Market

  • 20.1. Spain Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pulmonary Drug Delivery Devices Market

  • 21.1. Eastern Europe Pulmonary Drug Delivery Devices Market Overview
  • 21.2. Eastern Europe Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pulmonary Drug Delivery Devices Market

  • 22.1. Russia Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pulmonary Drug Delivery Devices Market

  • 23.1. North America Pulmonary Drug Delivery Devices Market Overview
  • 23.2. North America Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pulmonary Drug Delivery Devices Market

  • 24.1. USA Pulmonary Drug Delivery Devices Market Overview
  • 24.2. USA Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pulmonary Drug Delivery Devices Market

  • 25.1. Canada Pulmonary Drug Delivery Devices Market Overview
  • 25.2. Canada Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pulmonary Drug Delivery Devices Market

  • 26.1. South America Pulmonary Drug Delivery Devices Market Overview
  • 26.2. South America Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pulmonary Drug Delivery Devices Market

  • 27.1. Brazil Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pulmonary Drug Delivery Devices Market

  • 28.1. Middle East Pulmonary Drug Delivery Devices Market Overview
  • 28.2. Middle East Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pulmonary Drug Delivery Devices Market

  • 29.1. Africa Pulmonary Drug Delivery Devices Market Overview
  • 29.2. Africa Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pulmonary Drug Delivery Devices Market Competitive Landscape And Company Profiles

  • 30.1. Pulmonary Drug Delivery Devices Market Competitive Landscape
  • 30.2. Pulmonary Drug Delivery Devices Market Company Profiles
    • 30.2.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Air Liquide S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Medline Industries Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Pulmonary Drug Delivery Devices Market Other Major And Innovative Companies

  • 31.1. ResMed Inc.
  • 31.2. Dragerwerk AG And Co. KGaA
  • 31.3. Smiths Group plc
  • 31.4. AptarGroup Inc.
  • 31.5. Chiesi Farmaceutici S.p.A.
  • 31.6. Teleflex Incorporated
  • 31.7. Masimo Corporation
  • 31.8. Fisher And Paykel Healthcare Limited
  • 31.9. Invacare Corporation
  • 31.10. Vyaire Medical Inc.
  • 31.11. Inogen Inc.
  • 31.12. Drive DeVilbiss Healthcare Inc.
  • 31.13. Hovione
  • 31.14. Hamilton Medical AG
  • 31.15. GaleMed Corporation

32. Global Pulmonary Drug Delivery Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pulmonary Drug Delivery Devices Market

34. Recent Developments In The Pulmonary Drug Delivery Devices Market

35. Pulmonary Drug Delivery Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Pulmonary Drug Delivery Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Pulmonary Drug Delivery Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Pulmonary Drug Delivery Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer